948049-20-5

Basic information

• Product Name: C₁₀H₁₁BrO₃
• Synonyms: C₁₀H₁₁BrO₃
• CAS NO: 948049-20-5
• Molecular Weight: 259.1
• Mol File: 948049-20-5.mol

Chemical Properties

• CAS DataBase Reference: C₁₀H₁₁BrO₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₀H₁₁BrO₃(948049-20-5)
• EPA Substance Registry System: C₁₀H₁₁BrO₃(948049-20-5)

Safety Data

• Hazardous Substances Data: 948049-20-5(Hazardous Substances Data)

Upstream product

• 352287-97-9 (E)-3-(4-bromo-phenyl)-but-2-en-1-ol 
• 1381931-79-8 (Z)-3-(4-bromophenyl)but-2-en-1-ol 
• 99-90-1 para-bromoacetophenone 

Downstream Products

• 1381931-70-9 ethyl 6-(6-(1-(4-bromophenyl)vinyl)-1,2,4-trioxan-3-yl)-8-sec-butyl-2-oxo-2H-chromene-3-carboxylate 
• 1381931-69-6 methyl 6-(6-(1-(4-bromophenyl)vinyl)-1,2,4-trioxan-3-yl)-8-sec-butyl-2-oxo-2H-chromene-3-carboxylate 
• 1381931-67-4 methyl 6-(6-(1-(4-bromophenyl)vinyl)-1,2,4-trioxan-3-yl)-8-methyl-2-oxo-2H-chromene-3-carboxylate 
• 1381931-68-5 ethyl 6-(6-(1-(4-bromophenyl)vinyl)-1,2,4-trioxan-3-yl)-8-methyl-2-oxo-2H-chromene carboxylate 

Relevant articles and documents

Orally active antimalarials: Synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice

A new series of steroid-based 1,2,4-trioxanes 7a-f, 8a-f and 9b-e have been synthesized and evaluated for their antimalarial activity against multi-drug resistant Plasmodium yoelii in Swiss mice by oral route. The biological activity shows a strong depend

Coumarin-trioxane hybrids: Synthesis and evaluation as a new class of antimalarial scaffolds

First synthesis of novel coumarin-trioxane hybrids is reported. The synthesis was achieved via condensation of β-hydroxyhydroperoxides with coumarinic-aldehydes in presence of p-toluenesulfonic acid in good yields and the novel hybrids were evaluated for

Bile acid-based 1,2,4-trioxanes: Synthesis and antimalarial assessment(1)

A new series of bile acid-based trioxanes 23a-d, 24a-d, 25a-d, 26a, 26b, and 26d have been synthesized and assessed for their antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice by oral route. The antimalarial activity of these trioxanes showed a strong dependence on the side-chain length; shortening side-chain length lead to increase in activity. The antimalarial activity also showed even stronger dependence on the stereochemistry at C3 and C6 (C21 in Figure 5) of the trioxane moiety. Of the two diastereomers isolated of each of the trioxanes, more polar one was significantly more active than the less polar one. The more polar diastereomer of the trioxanes 26a, 26b, and 26d, were the most active compounds of the series. All these three trioxanes provided 100% protection at 24 mg/kg × 4 days. In this model β-arteether provided 100% and 20% protection at 48 mg/kg × 4 days and 24 mg/kg × 4 days, respectively.